Enwave Corp (NWVCF) 0.7692 $NWVCF EnWave Receives

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 3:13 AM

Enwave Corp [Cda] (NWVCF) 0.7692 $NWVCF

EnWave Receives Second Machine Purchase Order from Natural Nutrition d.b.a. Nanuva Ingredients
Marketwired - Mon May 02, 8:01AM CDT
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

today announced that it has received a second purchase order and deposit from Natural Nutrition, d.b.a. Nanuva Ingredients ("Nanuva"

, for a Radiant Energy Vacuum ("REV(TM)"

machine. This second REV(TM) machine will double the processing capacity of Nanuva and is scheduled for delivery in 2016.
ENW.VN: 1.010 (-0.020)

EnWave Awards Restricted Share Rights to Independent Directors
Marketwire Canada - Thu Mar 24, 7:23PM CDT
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

announced today that pursuant to the Restricted Share Plan ("Restricted Share Plan"

adopted in April 2015 by the Company, a total of 70,000 Restricted Share Rights ("Restricted Share Rights"

were awarded to the three independent directors of the Company on March 24, 2016. These Restricted Share Rights will not vest until three years from the date of award.
ENW.VN: 1.010 (-0.020)

EnWave Signs Technology Evaluation and License Option Agreement With Major Australasian Dairy Company, Ships Machine for Testing
Marketwire Canada - Mon Mar 21, 8:00AM CDT
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

today announced that it has signed a Technology Evaluation and License Option Agreement (the "TELOA"

with a major Australasian Dairy Company (the "ADC"

. The ADC will rent a small commercial-scale Radiant Energy Vacuum ("REVa"c"

machine to conduct a focused research program. This research program is scheduled to take place over the next three months. The ADC will use REVa"c technology to dehydrate dairy products with the goal of achieving significant cost savings by using REVa"c technology compared to freeze drying.
ENW.VN: 1.010 (-0.020)

EnWave Grants Stock Options to Executive Chairman
Marketwired - Mon Jan 04, 5:00PM CST
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

today announced that it has granted a total of 100,000 stock options to Mr. John P.A. Budreski, Executive Chairman of the Company, pursuant to its Share Option Plan (the "Plan"

. Each option will entitle Mr. Budreski to purchase one common share of the Company at an exercise price of $0.87 per share for a period of five years from this date. The options will vest in accordance to provisions set out in the Plan, or as otherwise required by the TSX Venture Exchange. The grant is subject to regulatory approval.
ENW.VN: 1.010 (-0.020)

EnWave Reports 2015 Annual Financial Results
Marketwired - Fri Dec 18, 8:01AM CST
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

today reported its annual results for the year ended September 30, 2015. EnWave's annual consolidated financial statements and MD&A are available on SEDAR at www.sedar.com and on our website at www.EnWave.net.
ENW.VN: 1.010 (-0.020)

EnWave Signs Commercial Royalty-Bearing License With Agricola Industrial La Lydia SA of Costa Rica for Fruit and Cheese Production, Receives Purchase Order
Marketwired - Tue Nov 24, 8:02AM CST
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

is pleased to announce that the Company has signed its sixteenth royalty-bearing commercial license agreement (the "License"

with Agricola Industrial La Lydia SA ("La Lydia"

. La Lydia, a family-owned company with more than 70 years of experience in agricultural activities and livestock, is a leading global producer of golden pineapples and a leading Costa Rican milk producer. They currently cultivate 700 hectares of agricultural land.
ENW.VN: 1.010 (-0.020)

EnWave Subsidiary Expands Availability of Moon Cheese(R) in Canada Through Global Coffee Company, Confirms Additional American Distribution Through Major Grocery Store Chains
Marketwired - Thu Nov 19, 8:03AM CST
EnWave Corporation (TSX VENTURE: ENW)(FRANKFURT: E4U) ("EnWave", or the "Company"

is pleased to announce that NutraDried LLP ("NutraDried"

, a subsidiary of the Company that is currently manufacturing, marketing and selling an innovative, all-natural cheese snack product ("Moon CheeseÂ®"

, will distribute Moon CheeseÂ® through 1,400 Canadian corporate stores of a major global coffee chain (the "Coffee Chain"

beginning in late 2015. This additional distribution will complement the current distribution of Moon CheeseÂ® in 7,500 corporate Coffee Chain locations in the United State of America.
ENW.VN: 1.010 (-0.020)

EnWave Commences Manufacturing of Equipment Under License Agreement With Pharmaceutical Partner
Marketwired - Wed Nov 18, 8:03AM CST
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

announced today that the Company has commenced the manufacturing (the "Manufacturing Phase"

of a scaled-up, non-GMP Radiant Energy Vacuum ("REV(TM)"

machine for a current Pharmaceutical Partner (the "Pharmaceutical Partner"

. Pursuant to an existing agreement between the Pharmaceutical Partner and EnWave signed in December 2014 (the "Agreement"

, the Pharmaceutical Partner will make an undisclosed milestone payment to the Company for successfully satisfying the proscribed design requirements and beginning the Manufacturing Phase.
ENW.VN: 1.010 (-0.020)

EnWave Signs Technology Evaluation and License Option Agreement With Nature's Touch Frozen Foods Inc. for Dehydrofrozen Fruit Products
Marketwired - Thu Nov 12, 8:02AM CST
EnWave Corporation (TSX VENTURE: ENW)(FRANKFURT: E4U) ("EnWave", or the "Company"

is pleased to announce today that the Company has signed a Technology Evaluation and License Option Agreement (the "Agreement"

with Nature's Touch Frozen Foods Inc. ("Nature's Touch"

. Nature's Touch is a leading global processor and distributor of frozen fruit with a significant presence in the United States of America, Canada, the United Kingdom, Australia, Japan and Taiwan.
ENW.VN: 1.010 (-0.020)

EnWave Extends Technology Evaluation and License Option Agreement With Jack Link's(R) Protein Snacks
Marketwired - Mon Nov 02, 8:02AM CST
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

confirmed today that the Company has extended the Technology Evaluation and License Option Agreement (the "Agreement"

that has been in place with Jack Link'sÂ® Protein Snacks ("Jack Link's"

since August 2014.
ENW.VN: 1.010 (-0.020)

EnWave Confirms Expansion and Extension of Moon Cheese(R) Distribution Through Major Coffee Chain by NutraDried LLP
Marketwired - Tue Oct 27, 8:03AM CDT
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

is pleased to confirm that NutraDried LLP ("NutraDried"

, a subsidiary of the Company that is currently manufacturing, marketing and selling an innovative, all-natural cheese snack product ("Moon CheeseÂ®"

, has received confirmation that Moon CheeseÂ® sales distribution will expand from 3,400 to 7,500 corporate stores of a major global coffee chain (the "Coffee Chain"

and that the distribution will extend into calendar year 2016.
ENW.VN: 1.010 (-0.020)

EnWave Corporation Announces Closing of $5 Million "Bought Deal" Private Placement
Marketwired - Thu Oct 22, 8:29AM CDT
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave" or the "Company"

is pleased to announce that it has completed its previously announced "bought deal" private placement offering (the "Offering"

to Cormark Securities Inc. (the "Underwriter"

of 6,250,000 units (the "Units"

of the Company at a purchase price of $0.80 per Unit (the "Offering Price"

, which includes the exercise in full of the underwriter's option, for aggregate gross proceeds of $5,000,000.
ENW.VN: 1.010 (-0.020)

EnWave Subsidiary, Hans Binder Maschinenbau GmbH, Files for Insolvency
Marketwired - Tue Sep 29, 8:31AM CDT
EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company"

today announced that Hans Binder Maschinenbau GmbH ("Binder"

, an 86.5% owned subsidiary of the Company, has filed for insolvency under German law. An individual will now be appointed by the court to facilitate receivership (the "Receiver"

. The Receiver will work with Binder's management, creditors, debtors and employees to either operate the business for a period of time and/or commence liquidation proceedings.
ENW.VN: 1.010 (-0.020)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...